Eli Lilly’s Olympics campaign rewind: Leverage pandemic’s focus on health to assert its brand and assert its point of viewnews2021-10-01T18:01:47+00:00October 1st, 2021|Fierce Pharma|
Agile Therapeutics scores soccer superstar Carli Lloyd to help build its women’s health brandnews2021-10-01T17:14:03+00:00October 1st, 2021|Fierce Pharma|
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?news2021-10-01T15:18:46+00:00October 1st, 2021|Fierce Pharma|
U.S. appeals court sides with Catalyst, calling FDA approval of Jacobus’ Ruzurgi ‘arbitrary,’ ‘capricious’ and unlawfulnews2021-10-01T15:16:08+00:00October 1st, 2021|Fierce Pharma|
Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka neuro pactnews2021-10-01T13:16:11+00:00October 1st, 2021|Fierce Pharma|
Moderna report says ‘human error’ to blame for contamination found in 3 vaccine lots from Rovi plantnews2021-10-01T12:37:52+00:00October 1st, 2021|Fierce Pharma|
Trouble builds for Merck’s $11.5B Acceleron buy as activist investor behind Gilead’s Immunomedics deal says too early, too cheapnews2021-10-01T10:07:35+00:00October 1st, 2021|Fierce Pharma|
Roche, Takeda and Pfizer notch top scores among rare disease patient advocacy groupsnews2021-09-30T15:39:52+00:00September 30th, 2021|Fierce Pharma|
Insider trading on 2 M&A deals made former Goldman Sachs compliance officer more than $77K, SEC chargesnews2021-09-30T15:35:17+00:00September 30th, 2021|Fierce Pharma|
Fujifilm completes construction of Netherlands production facility, enters validation stagenews2021-09-30T13:58:06+00:00September 30th, 2021|Fierce Pharma|
